Under construction – not a live service
Sign in
Taking peoplePhase 4

Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients

Key facts

Phase
Phase 4

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 60 years old?

Source: NCT06991972, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Khyber Teaching Hospital
Trial code
NCT06991972
Record updated
2 September 2025
Original description
This randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.Read full original descriptionShow less

Puncture to Repigment: A Comparative Analysis Of Needling vs. Microneedling Along With NBUVB in Treatment of Non-Segmental Vitiligo

This randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.

Inclusion: Both male and female; Age 15-60 years; Patients having vitiligo for more than 1 year.

Exclusion: Patients who had received systemic therapy in last 6 months; Any local infection at the treatment site; Patients with any bleeding disorder, coagulation defect or using anti platelets; Patients with tendency of keloid formation or hypertrophic scarring.

ClinicalTrials.gov NCT06991972